Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Research article

Association between elevated serum bilirubin levels with preserved lung function under conditions of exposure to air pollution

Authors: Udi Shapira, Rafael Y. Brezinski, Ori Rogowski, David Zeltser, Shlomo Berliner, Itzhak Shapira, Shani Shenhar-Tsarfaty, Elizabeth Fireman

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

High serum bilirubin levels have been shown to be associated with an improved pulmonary function test results. Their potential ability to similarly benefit pulmonary function in an environment of polluted air has not been tested. We retrospectively analyzed data of 15,605 apparently healthy individuals in order to evaluate the effect of serum bilirubin levels on forced expiratory volume in 1 s (FEV1).

Methods

Individuals attended the Tel-Aviv Medical Center Inflammatory Survey for a routine annual health check between February, 2002 and June, 2009 and were divided into low, medium and high serum bilirubin levels. Their FEV1 results were compared under various levels of air pollution. Air pollution and weather data were obtained from air pollution monitoring stations of the Israeli Ministry of Environmental Protection.

Results

The elevated serum bilirubin concentrations on FEV1 were evaluated under moderate and high pollution levels FEV1 and were significantly higher in participants with high blood bilirubin levels compared to medium or low levels (p < 0.001 and p = 0.018, respectively). Participants with high levels of bilirubin had preserved FEV1 under exposure to high and medium pollution levels of both Nitrogen Oxide (NOx) and Carbon Monoxide (CO) pollutants (p = 0.003 and p = 0.022, respectively). The multivariate regression analysis revealed that the influence of bilirubin under conditions of air pollution remained significant even after adjustment for FEV1 confounders, but the interaction was not significant.

Conclusions

Elevated serum bilirubin concentrations are associated with preserved lung function in healthy individuals in Israel exposed to high levels of air pollution.
Literature
2.
go back to reference Chen PC, Lai YM, Chan CC, Hwang JS, Yang CY, Wang JD. Short-term effect of ozone on the pulmonary function of children in primary school. Environ Health Perspect. 1999;107:921–5 (PMID: 10544161).CrossRef Chen PC, Lai YM, Chan CC, Hwang JS, Yang CY, Wang JD. Short-term effect of ozone on the pulmonary function of children in primary school. Environ Health Perspect. 1999;107:921–5 (PMID: 10544161).CrossRef
5.
6.
go back to reference Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Phys India. 2004;52:794–804. Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Phys India. 2004;52:794–804.
7.
go back to reference Berk PD, Howe RB, Bloomer JR, Berlin NI. Studies of bilirubin kinetics in normal adults. J Clin Investig. 1969;48:2176–90.CrossRef Berk PD, Howe RB, Bloomer JR, Berlin NI. Studies of bilirubin kinetics in normal adults. J Clin Investig. 1969;48:2176–90.CrossRef
8.
go back to reference Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968;61:748–55.CrossRef Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968;61:748–55.CrossRef
11.
go back to reference Sunghwan S, Young RC. Relationship between serum bilirubin levels and cardiovascular disease. PLoS ONE. 2018;13(2):e0193041.CrossRef Sunghwan S, Young RC. Relationship between serum bilirubin levels and cardiovascular disease. PLoS ONE. 2018;13(2):e0193041.CrossRef
12.
go back to reference Kunutsor SK, Bakker SJ, Gansevoort RT, Chowdhury R, Dullaart RP. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol. 2015;35(3):716–24.CrossRef Kunutsor SK, Bakker SJ, Gansevoort RT, Chowdhury R, Dullaart RP. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol. 2015;35(3):716–24.CrossRef
15.
go back to reference Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, Meredith, C Standardization of Spirometry Update. An official American thoracic society and European respiratory society technical statement. Am J Resp Crit Care Med. 2019;200:e70–88.CrossRef Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, Meredith, C Standardization of Spirometry Update. An official American thoracic society and European respiratory society technical statement. Am J Resp Crit Care Med. 2019;200:e70–88.CrossRef
17.
go back to reference von Eckardstein A, Kronenberg F, Probst-Hensch NM, Horsfall JL, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I. Serum bilirubin and risk of respiratory disease and death. JAMA. 2011;305:691–7.CrossRef von Eckardstein A, Kronenberg F, Probst-Hensch NM, Horsfall JL, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I. Serum bilirubin and risk of respiratory disease and death. JAMA. 2011;305:691–7.CrossRef
18.
go back to reference Leem A, Kim Y, Lee JH, Kim TH, Kim HY, et al. Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. Respir Res. 2019;20:279.CrossRef Leem A, Kim Y, Lee JH, Kim TH, Kim HY, et al. Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. Respir Res. 2019;20:279.CrossRef
19.
go back to reference Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56:1535–43.CrossRef Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56:1535–43.CrossRef
20.
go back to reference Satarung S, Moore M. Emerging role of cadmium and Heme Oxygenase 1 on Type 2 diabetes and cancer susceptibility Tohoku. J Exp Med. 2012;228:267–88. Satarung S, Moore M. Emerging role of cadmium and Heme Oxygenase 1 on Type 2 diabetes and cancer susceptibility Tohoku. J Exp Med. 2012;228:267–88.
21.
go back to reference Wu ML, Layne MD, Yet SF. Heme oxygenase-1 in environmental toxin-induced lung disease. J Toxicol Mech Methods. 2012;22(5):323–9.CrossRef Wu ML, Layne MD, Yet SF. Heme oxygenase-1 in environmental toxin-induced lung disease. J Toxicol Mech Methods. 2012;22(5):323–9.CrossRef
22.
go back to reference Motterlini R, Foresti R. Heme oxygenase-1 as a target for drug discovery. Antioxid Redox Signal. 2014;20–26:1810–6.CrossRef Motterlini R, Foresti R. Heme oxygenase-1 as a target for drug discovery. Antioxid Redox Signal. 2014;20–26:1810–6.CrossRef
23.
go back to reference Feng Zhang F, Wang S, Zhang M, Weng Z, Li P, Gan Y, Zhang L, et al. Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury. Stroke. 2012;43:1390–7.CrossRef Feng Zhang F, Wang S, Zhang M, Weng Z, Li P, Gan Y, Zhang L, et al. Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injury. Stroke. 2012;43:1390–7.CrossRef
24.
go back to reference Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheumatol. 2006;54:1132–42.CrossRef Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheumatol. 2006;54:1132–42.CrossRef
25.
go back to reference Ryter WS, Choi AMK. Targeting heme oxygenase-1/carbon monoxide for therapeutic modulation of inflammation. Transl Res. 2016;167:7–34.CrossRef Ryter WS, Choi AMK. Targeting heme oxygenase-1/carbon monoxide for therapeutic modulation of inflammation. Transl Res. 2016;167:7–34.CrossRef
Metadata
Title
Association between elevated serum bilirubin levels with preserved lung function under conditions of exposure to air pollution
Authors
Udi Shapira
Rafael Y. Brezinski
Ori Rogowski
David Zeltser
Shlomo Berliner
Itzhak Shapira
Shani Shenhar-Tsarfaty
Elizabeth Fireman
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01488-5

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.